BioNTech
BioNTech and Bristol Myers Squibb collaborate on bispecific antibody for solid tumours
June 6, 2025Research and Development BioNTech, Oncology, bispecific antibody treatment, bristol myers squibb, oncology, partnership
BioNTech and Bristol Myers Squibb (BMS) have entered a partnership to collaboratively develop and commercialise BNT327, BioNTech’s bispecific antibody, to …
BioNTech and Autolus announce CAR T-cell therapy collaboration
February 9, 2024Research and Development Autolus, BioNTech, CAR T-cell, Oncology, collaboration
BioNTech and Autolus Therapeutics have announced that they have entered a strategic collaboration intended to further both companies’ autologous CAR …
BioNTech achieves milestone at vaccine manufacturing site in Rwanda
December 19, 2023Manufacturing and Production BioNTech, Immunology, manufacturing, rwanda
BioNTech has announced that it has reached the next milestone in the establishment of its mRNA vaccine manufacturing capacities in …
BioNTech and CEPI partner for development of mRNA mpox vaccine
September 19, 2023Research and Development BioNTech, CEPI, Immunology, mpox
BioNTech and the Coalition for Epidemic Preparedness Innovations (CEPI) have announced a partnership to advance the development of mRNA-based vaccine …
Health Canada announce first full approval for Moderna COVID-19 vaccine
September 17, 2021Medical Communications AstraZeneca, BioNTech, Health Canada, Moderna, Pfizer, mrna
Canada has become the first country in the world to grant full approval to the Moderna vaccine, alongside confirmation for …
Pfizer commences process for full FDA approval of COVID-19 vaccine
May 10, 2021Sales and Marketing BioNTech, COVID-19 vaccine, FDA, Pfizer, Pfizer vaccine, pharma, pharma news
Pfizer and BioNTech have begun a Biologics Licence Application (BLA) with the FDA for full approval of their mRNA COVID-19 …
Pfizer vaccine 91.3% effective after six months, Phase III study shows
April 6, 2021Manufacturing and Production BioNTech, COVID-19, COVID-19 vaccine, Pfizer, Pfizer vaccine, pfizer-biontech vaccine
Pfizer and BioNTech’s follow-up study of their COVID-19 vaccine has confirmed the jab’s high efficacy after up to six months, …
EMA receives Pfizer and BioNTech’s filing for conditional approval of COVID-19 vaccine in Europe
December 1, 2020Manufacturing and Production, Sales and Marketing BioNTech, COVID-19, EMA, Pfizer, Vaccine
Pfizer and BioNTech have officially submitted their application to secure conditional marketing authorisation to the European Medicines Agency (EMA) for …
Pfizer and BioNTech to request FDA Emergency Use Authorisation for their COVID-19 vaccine today
November 20, 2020Medical Communications, Sales and Marketing BioNTech, COVID-19, Pfizer, Vaccine
Pfizer and BioNTech are reportedly gearing up to submit a formal application for Emergency Use Authorisation to the FDA later …
Pfizer/BioNTech’s COVID-19 vaccine shows up to 95% efficacy in final analysis, including in over-65s
November 18, 2020Research and Development BioNTech, COVID-19, Pfizer, Vaccine
Pfizer and BioNTech have backed up their promising interim Phase 3 data showing 90% efficacy for their COVID-19 vaccine candidate …
BioNTech Chief says COVID-19 vaccine could mean “normal winter” next year
November 16, 2020Research and Development, Sales and Marketing BioNTech, COVID-19, Pfizer, Vaccine
The advent of an effective vaccine could mean a return to normalcy by next winter, argues Professor Uğur Şahin, Professor …
Israel to reserve 8m doses of Pfizer/BioNTech’s COVID-19 vaccine
November 13, 2020Manufacturing and Production, Medical Communications BioNTech, COVID-19, Pfizer, Vaccine, israel
Israeli Health Minister Yuli Edelstein has confirmed the nation’s plans to strike an agreement with Pfizer to secure eight million …
Pfizer and BioNTech’s COVID-19 vaccine shows 90% efficacy in interim analysis
November 10, 2020Manufacturing and Production, Research and Development BioNTech, COVID-19, Pfizer, Vaccine
Pfizer and BioNTech have ignited a wave of hope with the announcement of positive Phase 3 data demonstrating that their …
EMA launches rolling regulatory review of Pfizer and BioNTech’s COVID-19 vaccine
October 7, 2020Research and Development, Sales and Marketing BioNTech, COVID-19, EMA, Pfizer, Vaccine
European Medicines Agency has launched a “rolling review” of the promising COVID-19 vaccine candidate BNT162b2 currently in development from BioNTech …
Japan reserves 120m doses of BioNTech’s COVID-19 vaccine
July 31, 2020Manufacturing and Production, Medical Communications BioNTech, COVID-19, Japan, Vaccine, pharma
Japan’s Ministry of Health, Labour and Welfare (MHLW) has sealed a deal with Pfizer and BioNTech to secure 120 million …
